Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Sangamo Biosciences Inc (SGMO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2016 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2016 Q2 | 60,000 | <0.01 | Reduce 84.20% | <0.01 | $5.78 | $347,000 | SEC |
| 2016 Q1 | 379,727 | 0.01 | Add 89.86% | <0.01 | $6.05 | $2,297,000 | SEC |
| 2015 Q4 | 200,000 | <0.01 | $9.13 | $1,826,000 | SEC | ||
| 2015 Q3 | 200,000 | <0.01 | Buy | <0.01 | $5.64 | $1,128,000 | SEC |
| 2015 Q2 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2015 Q1 | 559,780 | 0.02 | $15.68 | $8,777,000 | SEC | ||
| 2014 Q4 | 559,780 | 0.02 | Add 4.36% | <0.01 | $15.21 | $8,514,000 | SEC |
| 2014 Q3 | 536,380 | 0.02 | $10.79 | $5,785,000 | SEC | ||
| 2014 Q2 | 536,380 | 0.02 | Add 34.10% | <0.01 | $15.27 | $8,191,000 | SEC |
| 2014 Q1 | 400,000 | 0.02 | Reduce 52.81% | 0.02 | $18.08 | $7,232,000 | SEC |
| 2013 Q4 | 847,550 | 0.03 | $13.89 | $11,772,000 | SEC | ||
| 2013 Q3 | 847,550 | 0.03 | Add 99.73% | 0.02 | $10.48 | $8,882,000 | SEC |
| 2013 Q2 | 424,350 | 0.01 | Add 41.45% | <0.01 | $7.81 | $3,314,000 | SEC |
| 2013 Q1 | 300,000 | 0.01 | Buy | 0.01 | $9.56 | $2,868,000 | SEC |
| 2010 Q1 | 0 | 0.00 | Sell 100.00% | SEC | |||
| 2009 Q4 | 470 | 0.00 | $4.26 | $2,000 | SEC | ||
| 2009 Q3 | 470 | <0.01 | Reduce 99.82% | 0.02 | $89.36 | $42,000 | SEC |
| 2009 Q2 | 260,600 | 0.02 | Buy | 0.02 | $4.94 | $1,287,000 | SEC |
| 2009 Q1 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2008 Q4 | 288,000 | 0.02 | Buy | 0.02 | $3.48 | $1,002,000 | SEC |
| 2008 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2008 Q1 | 44,900 | 0.01 | Reduce 10.20% | <0.01 | $10.16 | $456,000 | SEC |
| 2007 Q4 | 50,000 | 0.01 | Buy | 0.01 | $13.10 | $655,000 | SEC |
| 2007 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2006 Q4 | 60,300 | <0.01 | Reduce 14.22% | <0.01 | $6.60 | $398,000 | SEC |
| 2006 Q3 | 70,300 | 0.01 | Buy | 0.01 | $5.56 | $391,000 | SEC |